Dipeptidyl peptidase ‐4 inhibitor and insulin combination treatment in type 2 diabetes and chronic kidney disease: a meta‐analysis

ConclusionsThis study demonstrated the effectiveness and safety of DPP-4 inhibitors bonded with insulin in patients with T2D and CKD, but the protective actions of this cure on kidney and cardiovascular outcomes, as well as the functions of other DPP-4 inhibitors, need to be affirmed by more good-quality RCTs.

Source: Journal of Diabetes Investigation - September 22, 2021 Category: Endocrinology Authors: Xianling Zhou, Heng Shi, Shiping Zhu, Haixia Wang, Shengyun Sun Tags: ORIGINAL ARTICLE Source Type: research